Safety and adverse events
nausea, abdominal pain, reflux
ADVERSE EVENTS, REFLUX
There was no evidence of a change between groups for their lipid profile, liver enzymes and kidney function tests. The majority of participants were tolerant without any side effects. In contrast, five subjects in the GSM group and two subjects in the placebo group reported adverse events including moderate indigestion, reflux, mild abdominal pain and nausea.